Daré Bioscience, Inc. (DARE)
NASDAQ·Healthcare·Biotechnology
$2.19
-2.23%
Mkt Cap $14.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $751.50K | $1.02M | +36.22% | -$0.24 | -$0.02 | +91.67% | — | — |
| Q4 2025 Nov 13, 2025 | $765.00K | $2.26K | -99.70% | -$0.33 | -$0.28 | +15.15% | — | — |
| Q3 2025 Aug 14, 2025 | $147.25K | -$21.17K | -114.38% | -$0.55 | -$0.45 | +18.18% | — | — |
| Q2 2025 May 13, 2025 | $600.00K | $25.43K | -95.76% | -$0.63 | -$0.50 | +20.63% | — | — |
| Q1 2025 Mar 31, 2025 | $1.00M | -$63.65K | -106.36% | -$0.66 | -$0.64 | +3.03% | — | — |
| Q4 2024 Nov 14, 2024 | $1.00M | $41.69K | -95.83% | -$0.60 | -$0.55 | +8.33% | — | — |
| Q3 2024 Aug 12, 2024 | $5.89M | $22.44K | -99.62% | -$0.57 | $1.52 | +366.67% | — | — |
| Q2 2024 May 14, 2024 | $260.00K | $9.30K | -96.42% | -$0.72 | -$0.84 | -16.67% | — | — |
| Q4 2023 Dec 30, 2023 | — | $1.81M | — | — | -$0.69 | — | — | — |
| Q4 2023 Nov 9, 2023 | $1.26M | $1.00M | -20.63% | -$1.20 | -$1.08 | +10.00% | — | — |
| Q3 2023 Aug 10, 2023 | $730.00K | — | — | -$1.20 | -$1.20 | +0.00% | — | — |
| Q2 2023 May 11, 2023 | $1.67M | — | — | -$1.20 | -$1.08 | +10.00% | — | — |
| Q1 2023 Mar 30, 2023 | $1.99M | $10.00B | +502412.56% | -$1.80 | -$2.28 | -26.67% | — | — |
| Q4 2022 Nov 10, 2022 | $7.96M | — | — | -$1.32 | -$0.96 | +27.27% | — | — |
| Q3 2022 Aug 9, 2022 | $10.00M | $10.00M | +0.00% | -$0.06 | $0.06 | +196.98% | — | — |
| Q2 2022 May 12, 2022 | $362.75K | — | — | -$1.68 | -$1.20 | +28.57% | — | — |
| Q1 2022 Mar 31, 2022 | $1.67M | — | — | -$2.52 | -$2.16 | +14.29% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$1.32 | -$2.16 | -63.64% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$1.80 | -$2.16 | -20.00% | — | — |
| Q2 2021 May 13, 2021 | $520.00K | — | — | -$2.76 | -$1.92 | +30.43% | — | — |